pI: 6.9131 |
Length (AA): 816 |
MW (Da): 90224 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
398 | 639 | 1u4q (A) | 1679 | 1920 | 18.00 | 0.000041 | 0.57 | 0.48 | -0.09 |
129 | 341 | 3q0x (A) | 19 | 218 | 22.00 | 0 | 1 | 0.447129 | -0.16 |
130 | 314 | 4ckn (B) | 130 | 314 | 99.00 | 0 | 1 | 1.39152 | -1.07 |
353 | 580 | 4tql (A) | 14 | 236 | 14.00 | 0 | 0.55 | 0.444512 | -1.15 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | metacyclic. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | amastigotes. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_129816)
Species | Accession | Gene Product |
---|---|---|
Cryptosporidium hominis | Chro.80062 | hypothetical protein |
Cryptosporidium parvum | cgd8_490 | uncharacterized large low complexity coiled coil protein |
Drosophila melanogaster | Dmel_CG15524 | Spindle assembly abnormal 6 ortholog (C. elegans) |
Echinococcus granulosus | EgrG_000597000 | spindle assembly abnormal protein 6 |
Echinococcus multilocularis | EmuJ_000597000 | spindle assembly abnormal protein 6 |
Homo sapiens | ENSG00000156876 | spindle assembly 6 homolog (C. elegans) |
Leishmania braziliensis | LbrM.34.4260 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_354350.1 | Spindle assembly abnormal protein 6 homolog |
Leishmania infantum | LinJ.35.4350 | hypothetical protein, conserved |
Leishmania major | LmjF.35.4280 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.4280 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000027959 | spindle assembly 6 homolog (C. elegans) |
Neospora caninum | NCLIV_044630 | hypothetical protein, conserved |
Plasmodium berghei | PBANKA_0106200 | spindle assembly abnormal protein 6 |
Plasmodium falciparum | PF3D7_0607600 | spindle assembly abnormal protein 6, putative |
Plasmodium knowlesi | PKNH_1142700 | spindle assembly abnormal protein 6, putative |
Plasmodium vivax | PVX_113545 | spindle assembly abnormal protein 6, putative |
Plasmodium yoelii | PY01398 | hypothetical protein |
Schistosoma japonicum | Sjp_0218560 | IPR008696,NAF1,domain-containing |
Schistosoma japonicum | Sjp_0309780 | expressed protein |
Schistosoma japonicum | Sjp_0067770 | Spindle assembly abnormal protein 6 homolog, putative |
Schistosoma mansoni | Smp_159110 | dystonin |
Schmidtea mediterranea | mk4.013448.00 | Spindle assembly abnormal protein 6 homolog |
Schmidtea mediterranea | mk4.011722.01 | |
Schmidtea mediterranea | mk4.026484.00 | Spindle assembly abnormal protein 6 homolog |
Schmidtea mediterranea | mk4.021442.00 | |
Schmidtea mediterranea | mk4.006369.01 | |
Trypanosoma brucei gambiense | Tbg972.9.6150 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.9.10550 | Spindle assembly abnormal protein 6 homolog |
Trypanosoma cruzi | TcCLB.506147.100 | Spindle assembly abnormal protein 6 homolog |
Toxoplasma gondii | TGME49_306430 | hypothetical protein |
Trichomonas vaginalis | TVAG_188420 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_587440 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.1930 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.1930 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.1930 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.1930 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0106200 | Plasmodium berghei | Dispensable | plasmo |
TGME49_306430 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.